ZA925523B - Pyrazole derivatives - Google Patents
Pyrazole derivativesInfo
- Publication number
- ZA925523B ZA925523B ZA925523A ZA925523A ZA925523B ZA 925523 B ZA925523 B ZA 925523B ZA 925523 A ZA925523 A ZA 925523A ZA 925523 A ZA925523 A ZA 925523A ZA 925523 B ZA925523 B ZA 925523B
- Authority
- ZA
- South Africa
- Prior art keywords
- pyrazole derivatives
- pyrazole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP91306870 | 1991-07-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA925523B true ZA925523B (en) | 1993-04-28 |
Family
ID=8208356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA925523A ZA925523B (en) | 1991-07-26 | 1992-07-22 | Pyrazole derivatives |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5227394A (es) |
| EP (1) | EP0525879A1 (es) |
| JP (1) | JPH05213934A (es) |
| KR (1) | KR930002322A (es) |
| AU (1) | AU647357B2 (es) |
| CA (1) | CA2074601A1 (es) |
| FI (1) | FI923325A (es) |
| IE (1) | IE922270A1 (es) |
| MX (1) | MX9204370A (es) |
| NO (1) | NO922945L (es) |
| ZA (1) | ZA925523B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR199800801T2 (xx) * | 1995-11-06 | 1998-08-21 | H. Lund-Beck A/S | Travmatik beyin yaralanmalar�n�n tedavisi. |
| US5733912A (en) * | 1997-02-19 | 1998-03-31 | Abbott Laboratories | 7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission |
| EP1014974B1 (en) | 1997-05-29 | 2004-08-11 | H. Lundbeck A/S | Treatment of schizophrenia and psychosis |
| BR0212983A (pt) * | 2001-10-17 | 2004-10-13 | Ucb Sa | Composto, uso do composto, e, intermediários de sìntese |
| GB0127731D0 (en) * | 2001-11-20 | 2002-01-09 | Coin Controls | Coin handling apparatus |
| FR2862647B1 (fr) | 2003-11-25 | 2008-07-04 | Aventis Pharma Sa | Derives de pyrazolyle, procede de preparation et intermediaires de ce procede a titre de medicaments et de compositions pharmaceutiques les renfermant |
| KR20090013815A (ko) * | 2006-05-04 | 2009-02-05 | 솔베이 파마슈티칼스 비. 브이 | 충동 조절 장애의 치료를 위한 무스카린 작용제 |
| WO2012052412A1 (de) | 2010-10-22 | 2012-04-26 | Bayer Cropscience Ag | Neue heterocylische verbindungen als schädlingsbekämpfungsmittel |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ219646A (en) * | 1986-03-27 | 1990-10-26 | Merck Sharp & Dohme | Oxadiazole derivatives of azacyclics for treating cns disorders |
| GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
| EP0307141B1 (en) * | 1987-09-10 | 1993-01-13 | MERCK SHARP & DOHME LTD. | Oxazoles and thiazoles for the treatment of senile dementia |
| IE63906B1 (en) * | 1987-11-13 | 1995-06-14 | Novo Nordisk As | Azabicyclic compounds and their preparation and use |
| US5043345A (en) * | 1989-02-22 | 1991-08-27 | Novo Nordisk A/S | Piperidine compounds and their preparation and use |
| EP0402056A3 (en) * | 1989-06-06 | 1991-09-04 | Beecham Group p.l.c. | Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| ATE136031T1 (de) * | 1989-10-07 | 1996-04-15 | Beecham Group Plc | Azabizyklische verbindungen, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen |
-
1992
- 1992-07-10 IE IE227092A patent/IE922270A1/en not_active Application Discontinuation
- 1992-07-20 AU AU20417/92A patent/AU647357B2/en not_active Ceased
- 1992-07-21 EP EP92202227A patent/EP0525879A1/en not_active Withdrawn
- 1992-07-21 FI FI923325A patent/FI923325A/fi not_active Application Discontinuation
- 1992-07-22 ZA ZA925523A patent/ZA925523B/xx unknown
- 1992-07-23 JP JP4196915A patent/JPH05213934A/ja active Pending
- 1992-07-24 CA CA002074601A patent/CA2074601A1/en not_active Abandoned
- 1992-07-24 NO NO92922945A patent/NO922945L/no unknown
- 1992-07-24 MX MX9204370A patent/MX9204370A/es unknown
- 1992-07-25 KR KR1019920013402A patent/KR930002322A/ko not_active Application Discontinuation
- 1992-07-27 US US07/919,806 patent/US5227394A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| IE922270A1 (en) | 1993-01-27 |
| FI923325A0 (fi) | 1992-07-21 |
| MX9204370A (es) | 1993-03-01 |
| US5227394A (en) | 1993-07-13 |
| AU2041792A (en) | 1993-01-28 |
| NO922945D0 (no) | 1992-07-24 |
| JPH05213934A (ja) | 1993-08-24 |
| FI923325A (fi) | 1993-01-27 |
| NO922945L (no) | 1993-01-27 |
| EP0525879A1 (en) | 1993-02-03 |
| AU647357B2 (en) | 1994-03-17 |
| CA2074601A1 (en) | 1993-01-27 |
| KR930002322A (ko) | 1993-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL116507A (en) | Pyrazole derivatives | |
| GR3023621T3 (en) | 3-Hydroxy-4-aryl-5-oxo-pyrazolin derivatives | |
| HU9203994D0 (en) | Imidazo-pyridine derivatives | |
| GB9111130D0 (en) | Azole derivatives | |
| HU9202768D0 (en) | Cyano-phenyl-pyrrole derivatives | |
| HU9202388D0 (en) | Aryl-alkyl-amine derivatives | |
| ZA92278B (en) | 3-quinuclidine derivatives | |
| GB9102804D0 (en) | Heterocyclic derivatives | |
| EP0520435A3 (en) | Dc-89 derivatives | |
| ZA922976B (en) | 4-Aryl-3-heteroarylureidoquinoline derivatives | |
| ZA925523B (en) | Pyrazole derivatives | |
| GB9125002D0 (en) | Azole derivatives | |
| GB9226735D0 (en) | Azole derivatives | |
| HU9200011D0 (en) | Trifluoro-methyl-1-carba(1-dethia)-cepheme derivatives | |
| GB2262739B (en) | Benzofuranylimidazole derivatives | |
| GB9102423D0 (en) | Pryimidinyl-and triazinylsalicyl-and-picolinylaldehyde derivatives | |
| HU9204001D0 (en) | New imidazole derivatives | |
| GB9119267D0 (en) | Pyrazole derivatives | |
| EP0519370A3 (en) | Heterocyclic derivatives | |
| HU9200105D0 (en) | Bipiridyl derivatives | |
| GB9104125D0 (en) | Azole derivatives | |
| GB9101380D0 (en) | Azole derivatives | |
| ZA942400B (en) | Pyrazole derivatives | |
| HU9400655D0 (en) | C-linked pyrazole derivatives | |
| HU913909D0 (en) | New imidazole derivatives |